Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES

Expression of Antigen Evaluated for Prostate Cancer

By Labmedica International staff writers
Posted on 14 Feb 2012
The expression of the cancer/testis antigen, A-kinase anchor protein 4 (AKAP-4), has been evaluated in prostate cancer (PC) patients.

The exploitation tumor-associated antigens, not only for screening purposes, but also as targets for tumor immunotherapy underlines their relevance in oncology and is due to features frequently shared by molecular biomarkers and tumor antigens.

Scientists at Texas Technical University (Lubbock, TX, USA) analyzed normal prostate tissues, 15 patients with PC and the LnCAP PC cell line by immunohistochemistry. The immunogenicity of AKAP-4 was tested through indirect enzyme-linked immunosorbent assay (ELISA) on sera from cancer patients and healthy subjects. In vitro AKAP-4-specific cytotoxic lymphocytes were generated from peripheral blood mononuclear cells. Reverse transcriptase polymerase chain reaction (RT-PCR) was used to measure AKAP-4 messenger ribonucleic acid (mRNA) expression.

The AKAP-4 was shown both at the cytoplasmic and surface levels of the LnCAP PC cell line. AKAP-4 was also highly expressed in PC cells from patients. Specific anti-AKAP-4 circulating immunoglobulins were detected in AKAP-4 positive subjects. The use of recombinant AKAP-4-loaded autologous dendritic cells generated AKAP-4-specific and human leukocyte antigen-1 (HLA-I)-restricted cytotoxic T lymphocytes able to kill PC cells in vitro. Further characterization indicated a T-helper cell (Th-1) skewing in the cytokine secretion profile of these cells.

The indirect ELISA was performed using specific reagents from Pierce (Rockford, IL, USA) and the ELISA for T Cell Cytokine Expression used sandwich ELISA kits from U-CyTech (Utrecht, The Netherlands). The authors concluded that the aberrant expression of AKAP-4 in PC will potentially be developed as a biomarker in PC and is a potential target for immunotherapy. The study was published in the January 2012 issue of the journal the Prostate.

Related Links:

Texas Technical University
Pierce
U-CyTech



KARL HECHT GMBH & CO KG
MEDLAB Asia
CELLAVISION AB
PERIPHERAL VISIONS INC

Channels

Genetic Tests

view channel
Image: Histopathology of tuberculoid leprosy in a skin section (Photo courtesy Dr. D.S. Ridley, Wellcome Images).

Genes Discovered Influence Risk of Developing Leprosy

Leprosy, a chronic dermatological and neurological disease, is caused by infection with Mycobacterium leprae, and its manifestation, progression and prognosis are strongly associated with the proficiency... Read more

Hematology

view channel
Image: Plastic bag containing 0.5 to 0.7 liters of packed red blood cells in citrate, phosphate, dextrose, and adenine (CPDA) solution (Photo courtesy of Fresenius HemoCare).

Transfusion Protocols Compared After Cardiac Surgery

Unnecessary blood transfusions may increase healthcare costs both directly, because blood is an increasingly scarce and expensive resource, and indirectly due to the complications associated with transfusion.... Read more

Industry News

view channel

Latin America’s IVD Sector Exceeds USD 2 Billion, Brazil leads

The Latin American in vitro diagnostics (IVD) sector was estimated at USD 2.4 billion in 2014. Population growth, government insurance, newly insured patients, and updated healthcare facilities have driven growth in the region and will continue to propel demand, according to Kalorama Information (New York, NY, USA).... Read more
 

Events

06 Apr 2015 - 08 Apr 2015
07 Apr 2015 - 09 Apr 2015
13 Apr 2015 - 16 Apr 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.